Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-09 1:17 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | JPMORGAN CHASE & CO JPM | 15,573 0% | -3,659,241 (-99.58%) | View |
| 2024-02-14 4:58 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | CITADEL ADVISORS LLC | 1,236,850 2.4% | -1,022,891 (-45.27%) | View |
| 2024-02-14 4:02 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 0 0% | -3,163,795 (Position Closed) | View |
| 2024-02-14 3:38 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | ArrowMark Colorado Holdings LLC | 2,714,143 5.31% | 2,714,143 (New Position) | View |
| 2024-02-14 09:18 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | Avoro Capital Advisors LLC | 0 0% | -3,060,000 (Position Closed) | View |
| 2024-02-14 07:52 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 0 0% | -4,356,920 (Position Closed) | View |
| 2024-02-13 5:12 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | VANGUARD GROUP INC | 2,405,307 4.7% | -348,299 (-12.65%) | View |
| 2024-01-29 3:26 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | BlackRock Inc. BLK | 3,229,797 6.3% | -1,447,231 (-30.94%) | View |
| 2024-01-23 09:40 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | JPMORGAN CHASE & CO JPM | 3,674,814 7.1% | -329,953 (-8.24%) | View |
| 2024-01-23 09:07 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | STATE STREET CORP STT | 723,454 1.41% | 76,904 (+11.89%) | View |
| 2023-08-23 4:56 pm Sale | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,563,077 13.5% | -26,253 (-0.40%) | View |
| 2023-07-07 4:35 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | BlackRock Inc. BLK | 4,677,028 10.2% | 1,225,661 (+35.51%) | View |
| 2023-05-19 4:05 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | CITADEL ADVISORS LLC | 2,259,741 4.9% | 875,242 (+63.22%) | View |
| 2023-05-10 09:19 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | STATE STREET CORP STT | 646,550 1.41% | -2,660,686 (-80.45%) | View |
| 2023-02-14 1:10 pm Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Boxer Capital LLC | 3,163,795 6.9% | 325,559 (+11.47%) | View |
| 2023-02-14 10:07 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 4,356,920 9.5% | 1,375,960 (+46.16%) | View |
| 2023-02-14 09:35 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | Avoro Capital Advisors LLC | 3,060,000 6.7% | 1,595,000 (+108.87%) | View |
| 2023-02-14 08:26 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | CITADEL ADVISORS LLC | 1,384,499 3% | -1,025,343 (-42.55%) | View |
| 2023-02-10 1:00 pm Sale | 13G | PMV PHARMACEUTICALS INC PMVP | INTERWEST PARTNERS X LP | 1,714,540 3.8% | -1,535,004 (-47.24%) | View |
| 2023-02-10 11:26 am Sale | 13G | PMV PHARMACEUTICALS INC PMVP | STATE STREET CORP STT | 3,307,236 7.24% | -1,864,254 (-36.05%) | View |